Acesis Holdings Corpの企業情報(従業員数・代表者名など)
企業情報
特色 | Acesis Holdings Corp is a United States-based company. The Company operates as pre-phase I (first-in-man (FIM) clinical, biotechnology company focused on men’s health. The Company develops treatments for low testosterone levels in males (Low-T) known as T-deficiency or male hypogonadism. Its business model is to develop non-steroid product candidates that transform the treatment of men with Low-T. The Company’s lead peptide, ACE-167, has been designed to act through a molecular mechanism to induce the Leydi |
---|---|
英文社名 | Acesis Holdings Corp |
本社所在地 | 9233 Park Meadows Rive, Suite 108 LONE TREE, CO 80124 USA |
電話番号 | 720 389-0650 |
設立年月 | 2022年1月 |
代表者名 | Konstantinos Karatzas |
業種名 | 医療関連(Health Care) |
市場名 | --- |
従業員数 | --- |
ウェブサイト | --- |